Quarterly Result18 May 2026, 08:51 pm
Sun Pharma Advanced Research Co Audited Financial Results
AI Summary
Sun Pharma Advanced Research Company Ltd. announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, during its Board of Directors meeting held on May 18, 2026. The statutory auditors have issued an unmodified opinion on these financial results. The meeting commenced at 05:30 P.M. (1ST) and concluded at 07:00 P.M. (1ST).
Key Highlights
- Audited standalone and consolidated financial results approved for FY26.
- Board meeting held on May 18, 2026, to approve results.
- Statutory auditors issued an unmodified opinion on the financial results.
- Results are for the quarter and year ended March 31, 2026.
Price Impact
More from SPARC